Abstract
In the current climate of decreasing margins and increased competition marketing, activities should and must give measurable return on investment (ROI). However, very few pharmaceutical marketers can accurately predict whether their operations plan will increase or decrease market share and by what amount. If they did predict direction accurately they would be hard pressed to really know which elements of their marketing mix (eg salesforce, journal advertising, opinion leader programmes, direct mail, e-Business activities etc) were directly contributing and by how much, and which aspects of their current programme were in fact contributing to impact in market share. This paper will demonstrate how pharmaceutical marketers can use doctor sentiment and benchmarking to: (1) Measure the impact of their current marketing campaigns in terms of what is leading to increases and decreases in market share. (2) Manage marketing to maximize impact to increase market share and ROI. (3) Predict market share direction w...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
